The Antifungal infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Antifungal infection Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Powders accounting for % of the Antifungal infection Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polyenes segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Antifungal infection Therapeutics include Scynexis, Sanofi-Aventis, Pfizer, Novartis, and Merck & Co, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antifungal infection Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types
Market segment by Application, can be divided into
Powders
Pastes
Ointments
Drugs
Other Applications
Market segment by players, this report covers
Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Antifungal infection Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Antifungal infection Therapeutics, with revenue, gross margin and global market share of Antifungal infection Therapeutics from 2019 to 2022.
Chapter 3, the Antifungal infection Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Antifungal infection Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Antifungal infection Therapeutics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Antifungal infection Therapeutics
1.2 Classification of Antifungal infection Therapeutics by Type
1.2.1 Overview: Global Antifungal infection Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Antifungal infection Therapeutics Revenue Market Share by Type in 2021
1.2.3 Polyenes
1.2.4 Echinocandins
1.2.5 Azoles
1.2.6 Allylamines
1.2.7 Other Drug types
1.3 Global Antifungal infection Therapeutics Market by Application
1.3.1 Overview: Global Antifungal infection Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Powders
1.3.3 Pastes
1.3.4 Ointments
1.3.5 Drugs
1.3.6 Other Applications
1.4 Global Antifungal infection Therapeutics Market Size & Forecast
1.5 Global Antifungal infection Therapeutics Market Size and Forecast by Region
1.5.1 Global Antifungal infection Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Antifungal infection Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Antifungal infection Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Antifungal infection Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Antifungal infection Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Antifungal infection Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Antifungal infection Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antifungal infection Therapeutics Market Drivers
1.6.2 Antifungal infection Therapeutics Market Restraints
1.6.3 Antifungal infection Therapeutics Trends Analysis
2 Company Profiles
2.1 Scynexis
2.1.1 Scynexis Details
2.1.2 Scynexis Major Business
2.1.3 Scynexis Antifungal infection Therapeutics Product and Solutions
2.1.4 Scynexis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Scynexis Recent Developments and Future Plans
2.2 Sanofi-Aventis
2.2.1 Sanofi-Aventis Details
2.2.2 Sanofi-Aventis Major Business
2.2.3 Sanofi-Aventis Antifungal infection Therapeutics Product and Solutions
2.2.4 Sanofi-Aventis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Sanofi-Aventis Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Antifungal infection Therapeutics Product and Solutions
2.3.4 Pfizer Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antifungal infection Therapeutics Product and Solutions
2.4.4 Novartis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Merck & Co
2.5.1 Merck & Co Details
2.5.2 Merck & Co Major Business
2.5.3 Merck & Co Antifungal infection Therapeutics Product and Solutions
2.5.4 Merck & Co Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Merck & Co Recent Developments and Future Plans
2.6 Kramer Laboratories
2.6.1 Kramer Laboratories Details
2.6.2 Kramer Laboratories Major Business
2.6.3 Kramer Laboratories Antifungal infection Therapeutics Product and Solutions
2.6.4 Kramer Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Kramer Laboratories Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Antifungal infection Therapeutics Product and Solutions
2.7.4 Johnson & Johnson Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 ID Sigma-Aldrich Corporation
2.8.1 ID Sigma-Aldrich Corporation Details
2.8.2 ID Sigma-Aldrich Corporation Major Business
2.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product and Solutions
2.8.4 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 ID Sigma-Aldrich Corporation Recent Developments and Future Plans
2.9 Glenmark Pharmaceuticals
2.9.1 Glenmark Pharmaceuticals Details
2.9.2 Glenmark Pharmaceuticals Major Business
2.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
2.9.4 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
2.10 Glaxosmithkline
2.10.1 Glaxosmithkline Details
2.10.2 Glaxosmithkline Major Business
2.10.3 Glaxosmithkline Antifungal infection Therapeutics Product and Solutions
2.10.4 Glaxosmithkline Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Glaxosmithkline Recent Developments and Future Plans
2.11 Enzon Pharmaceuticals
2.11.1 Enzon Pharmaceuticals Details
2.11.2 Enzon Pharmaceuticals Major Business
2.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
2.11.4 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Enzon Pharmaceuticals Recent Developments and Future Plans
2.12 Bayer Healthcare
2.12.1 Bayer Healthcare Details
2.12.2 Bayer Healthcare Major Business
2.12.3 Bayer Healthcare Antifungal infection Therapeutics Product and Solutions
2.12.4 Bayer Healthcare Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Bayer Healthcare Recent Developments and Future Plans
2.13 Astellas Pharma
2.13.1 Astellas Pharma Details
2.13.2 Astellas Pharma Major Business
2.13.3 Astellas Pharma Antifungal infection Therapeutics Product and Solutions
2.13.4 Astellas Pharma Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Astellas Pharma Recent Developments and Future Plans
2.14 Asperqillus
2.14.1 Asperqillus Details
2.14.2 Asperqillus Major Business
2.14.3 Asperqillus Antifungal infection Therapeutics Product and Solutions
2.14.4 Asperqillus Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Asperqillus Recent Developments and Future Plans
2.15 Alternaria
2.15.1 Alternaria Details
2.15.2 Alternaria Major Business
2.15.3 Alternaria Antifungal infection Therapeutics Product and Solutions
2.15.4 Alternaria Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Alternaria Recent Developments and Future Plans
2.16 Abbott Laboratories
2.16.1 Abbott Laboratories Details
2.16.2 Abbott Laboratories Major Business
2.16.3 Abbott Laboratories Antifungal infection Therapeutics Product and Solutions
2.16.4 Abbott Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Abbott Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antifungal infection Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Antifungal infection Therapeutics Players Market Share in 2021
3.2.2 Top 10 Antifungal infection Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Antifungal infection Therapeutics Players Head Office, Products and Services Provided
3.4 Antifungal infection Therapeutics Mergers & Acquisitions
3.5 Antifungal infection Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antifungal infection Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Antifungal infection Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Antifungal infection Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Antifungal infection Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Antifungal infection Therapeutics Revenue by Type (2017-2028)
6.2 North America Antifungal infection Therapeutics Revenue by Application (2017-2028)
6.3 North America Antifungal infection Therapeutics Market Size by Country
6.3.1 North America Antifungal infection Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Antifungal infection Therapeutics Revenue by Type (2017-2028)
7.2 Europe Antifungal infection Therapeutics Revenue by Application (2017-2028)
7.3 Europe Antifungal infection Therapeutics Market Size by Country
7.3.1 Europe Antifungal infection Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Region
8.3.1 Asia-Pacific Antifungal infection Therapeutics Revenue by Region (2017-2028)
8.3.2 China Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Antifungal infection Therapeutics Revenue by Type (2017-2028)
9.2 South America Antifungal infection Therapeutics Revenue by Application (2017-2028)
9.3 South America Antifungal infection Therapeutics Market Size by Country
9.3.1 South America Antifungal infection Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antifungal infection Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Antifungal infection Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Country
10.3.1 Middle East & Africa Antifungal infection Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Antifungal infection Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Antifungal infection Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Antifungal infection Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Antifungal infection Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Antifungal infection Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Antifungal infection Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. Scynexis Corporate Information, Head Office, and Major Competitors
Table 7. Scynexis Major Business
Table 8. Scynexis Antifungal infection Therapeutics Product and Solutions
Table 9. Scynexis Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi-Aventis Major Business
Table 12. Sanofi-Aventis Antifungal infection Therapeutics Product and Solutions
Table 13. Sanofi-Aventis Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Antifungal infection Therapeutics Product and Solutions
Table 17. Pfizer Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Antifungal infection Therapeutics Product and Solutions
Table 21. Novartis Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Merck & Co Corporate Information, Head Office, and Major Competitors
Table 23. Merck & Co Major Business
Table 24. Merck & Co Antifungal infection Therapeutics Product and Solutions
Table 25. Merck & Co Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Kramer Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Kramer Laboratories Major Business
Table 28. Kramer Laboratories Antifungal infection Therapeutics Product and Solutions
Table 29. Kramer Laboratories Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Antifungal infection Therapeutics Product and Solutions
Table 33. Johnson & Johnson Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. ID Sigma-Aldrich Corporation Corporate Information, Head Office, and Major Competitors
Table 35. ID Sigma-Aldrich Corporation Major Business
Table 36. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product and Solutions
Table 37. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Glenmark Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Glenmark Pharmaceuticals Major Business
Table 40. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
Table 41. Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Glaxosmithkline Corporate Information, Head Office, and Major Competitors
Table 43. Glaxosmithkline Major Business
Table 44. Glaxosmithkline Antifungal infection Therapeutics Product and Solutions
Table 45. Glaxosmithkline Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Enzon Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Enzon Pharmaceuticals Major Business
Table 48. Enzon Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
Table 49. Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Bayer Healthcare Corporate Information, Head Office, and Major Competitors
Table 51. Bayer Healthcare Major Business
Table 52. Bayer Healthcare Antifungal infection Therapeutics Product and Solutions
Table 53. Bayer Healthcare Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Astellas Pharma Major Business
Table 56. Astellas Pharma Antifungal infection Therapeutics Product and Solutions
Table 57. Astellas Pharma Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Asperqillus Corporate Information, Head Office, and Major Competitors
Table 59. Asperqillus Major Business
Table 60. Asperqillus Antifungal infection Therapeutics Product and Solutions
Table 61. Asperqillus Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Alternaria Corporate Information, Head Office, and Major Competitors
Table 63. Alternaria Major Business
Table 64. Alternaria Antifungal infection Therapeutics Product and Solutions
Table 65. Alternaria Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 67. Abbott Laboratories Major Business
Table 68. Abbott Laboratories Antifungal infection Therapeutics Product and Solutions
Table 69. Abbott Laboratories Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Antifungal infection Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Antifungal infection Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Antifungal infection Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Antifungal infection Therapeutics Players Head Office, Products and Services Provided
Table 74. Antifungal infection Therapeutics Mergers & Acquisitions in the Past Five Years
Table 75. Antifungal infection Therapeutics New Entrants and Expansion Plans
Table 76. Global Antifungal infection Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 77. Global Antifungal infection Therapeutics Revenue Share by Type (2017-2022)
Table 78. Global Antifungal infection Therapeutics Revenue Forecast by Type (2023-2028)
Table 79. Global Antifungal infection Therapeutics Revenue by Application (2017-2022)
Table 80. Global Antifungal infection Therapeutics Revenue Forecast by Application (2023-2028)
Table 81. North America Antifungal infection Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Antifungal infection Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Antifungal infection Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Antifungal infection Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Antifungal infection Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Antifungal infection Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Antifungal infection Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Antifungal infection Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Antifungal infection Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Antifungal infection Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Antifungal infection Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Antifungal infection Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Antifungal infection Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Antifungal infection Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Antifungal infection Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Antifungal infection Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Antifungal infection Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Antifungal infection Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Antifungal infection Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Antifungal infection Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Antifungal infection Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Antifungal infection Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Antifungal infection Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Antifungal infection Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Antifungal infection Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Antifungal infection Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Antifungal infection Therapeutics Picture
Figure 2. Global Antifungal infection Therapeutics Revenue Market Share by Type in 2021
Figure 3. Polyenes
Figure 4. Echinocandins
Figure 5. Azoles
Figure 6. Allylamines
Figure 7. Other Drug types
Figure 8. Antifungal infection Therapeutics Revenue Market Share by Application in 2021
Figure 9. Powders Picture
Figure 10. Pastes Picture
Figure 11. Ointments Picture
Figure 12. Drugs Picture
Figure 13. Other Applications Picture
Figure 14. Global Antifungal infection Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Antifungal infection Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Antifungal infection Therapeutics Revenue Market Share by Region (2017-2028)
Figure 17. Global Antifungal infection Therapeutics Revenue Market Share by Region in 2021
Figure 18. North America Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Antifungal infection Therapeutics Market Drivers
Figure 24. Antifungal infection Therapeutics Market Restraints
Figure 25. Antifungal infection Therapeutics Market Trends
Figure 26. Scynexis Recent Developments and Future Plans
Figure 27. Sanofi-Aventis Recent Developments and Future Plans
Figure 28. Pfizer Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Merck & Co Recent Developments and Future Plans
Figure 31. Kramer Laboratories Recent Developments and Future Plans
Figure 32. Johnson & Johnson Recent Developments and Future Plans
Figure 33. ID Sigma-Aldrich Corporation Recent Developments and Future Plans
Figure 34. Glenmark Pharmaceuticals Recent Developments and Future Plans
Figure 35. Glaxosmithkline Recent Developments and Future Plans
Figure 36. Enzon Pharmaceuticals Recent Developments and Future Plans
Figure 37. Bayer Healthcare Recent Developments and Future Plans
Figure 38. Astellas Pharma Recent Developments and Future Plans
Figure 39. Asperqillus Recent Developments and Future Plans
Figure 40. Alternaria Recent Developments and Future Plans
Figure 41. Abbott Laboratories Recent Developments and Future Plans
Figure 42. Global Antifungal infection Therapeutics Revenue Share by Players in 2021
Figure 43. Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Antifungal infection Therapeutics Revenue Market Share in 2021
Figure 45. Global Top 10 Players Antifungal infection Therapeutics Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Antifungal infection Therapeutics Revenue Share by Type in 2021
Figure 48. Global Antifungal infection Therapeutics Market Share Forecast by Type (2023-2028)
Figure 49. Global Antifungal infection Therapeutics Revenue Share by Application in 2021
Figure 50. Global Antifungal infection Therapeutics Market Share Forecast by Application (2023-2028)
Figure 51. North America Antifungal infection Therapeutics Sales Market Share by Type (2017-2028)
Figure 52. North America Antifungal infection Therapeutics Sales Market Share by Application (2017-2028)
Figure 53. North America Antifungal infection Therapeutics Revenue Market Share by Country (2017-2028)
Figure 54. United States Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Antifungal infection Therapeutics Sales Market Share by Type (2017-2028)
Figure 58. Europe Antifungal infection Therapeutics Sales Market Share by Application (2017-2028)
Figure 59. Europe Antifungal infection Therapeutics Revenue Market Share by Country (2017-2028)
Figure 60. Germany Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Antifungal infection Therapeutics Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Antifungal infection Therapeutics Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Antifungal infection Therapeutics Revenue Market Share by Region (2017-2028)
Figure 68. China Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Antifungal infection Therapeutics Sales Market Share by Type (2017-2028)
Figure 75. South America Antifungal infection Therapeutics Sales Market Share by Application (2017-2028)
Figure 76. South America Antifungal infection Therapeutics Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Antifungal infection Therapeutics Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Antifungal infection Therapeutics Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Antifungal infection Therapeutics Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Antifungal infection Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source